TCM Biotech International Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	292.57	245.07	232.98	504.13	89.85	58.26
Short-Term Investments	300	300	300	-	0.09	-
Cash & Short-Term Investments	592.57	545.07	532.98	504.13	89.94	58.26
Cash Growth	11.18%	2.27%	5.72%	460.55%	54.38%	70.01%
Accounts Receivable	156.3	151.37	139.96	259.08	225.83	190.68
Other Receivables	0.13	0.13	1.69	3.61	3.94	0.03
Receivables	156.43	151.5	141.65	262.69	229.77	190.71
Inventory	170.46	156.13	132.24	208.36	193.25	203.33
Prepaid Expenses	9.79	5.67	4.96	4.46	0.65	17.08
Other Current Assets	0.23	0.1	0.15	1.51	0.13	0.74
Total Current Assets	929.47	858.46	811.98	981.15	513.74	470.11
Property, Plant & Equipment	275.7	280.67	291.91	293.71	301.74	285.36
Long-Term Investments	27.52	27.52	30	-	-	-
Other Intangible Assets	1.65	1.92	5.06	8.01	10.24	13.21
Long-Term Deferred Tax Assets	1.19	1.32	1.02	0.98	1.63	4.2
Long-Term Deferred Charges	15.66	15.66	15.66	15.66	15.66	16.26
Other Long-Term Assets	18.98	18.63	26.73	23.41	19.87	30.92
Total Assets	1,270	1,204	1,182	1,323	862.87	820.06
Accounts Payable	60.02	48.38	20.69	64.53	88.81	55.54
Accrued Expenses	14.65	27.66	26.47	50.18	52.01	36.84
Short-Term Debt	-	-	-	44	44	44
Current Portion of Long-Term Debt	1.26	3.45	3.05	5.19	10.44	9.21
Current Portion of Leases	3.66	3.9	3.72	1.68	2.95	1.84
Current Income Taxes Payable	3.32	3.39	4.03	2.59	2.35	-
Current Unearned Revenue	18.32	10.29	2.84	2.25	2.76	5.12
Other Current Liabilities	41.95	17.83	21.11	27.96	21.54	23.38
Total Current Liabilities	143.17	114.89	81.9	198.38	224.84	175.93
Long-Term Debt	8.64	24.76	28.54	59.69	93.58	104.51
Long-Term Leases	4.32	5.09	8.16	4.81	6.49	1.45
Long-Term Unearned Revenue	3.23	3.23	3.23	3.23	-	18.2
Pension & Post-Retirement Benefits	-	0.89	1.46	1.5	1	1.6
Long-Term Deferred Tax Liabilities	-	-	0	-	0.01	-
Other Long-Term Liabilities	0.82	-	-	0.27	0.27	0.16
Total Liabilities	160.18	148.86	123.28	267.88	326.2	301.84
Common Stock	590.49	590.49	590.49	590.49	475.92	475.92
Additional Paid-In Capital	445.27	415.77	415.77	415.77	13.82	13.82
Retained Earnings	4.03	51.63	52.87	48.85	47.04	28.47
Comprehensive Income & Other	70.22	-2.57	-0.05	-0.07	-0.11	0.01
Shareholders' Equity	1,110	1,055	1,059	1,055	536.67	518.22
Total Liabilities & Equity	1,270	1,204	1,182	1,323	862.87	820.06
Total Debt	17.88	37.2	43.46	115.38	157.46	161
Net Cash (Debt)	574.69	507.87	489.52	388.76	-67.52	-102.75
Net Cash Growth	17.40%	3.75%	25.92%	-	-	-
Net Cash Per Share	9.73	8.60	8.29	7.33	-1.38	-2.11
Filing Date Shares Outstanding	59.05	59.05	59.05	59.05	49.05	49.05
Total Common Shares Outstanding	59.05	59.05	59.05	59.05	49.05	49.05
Working Capital	786.3	743.57	730.08	782.78	288.9	294.18
Book Value Per Share	18.80	17.87	17.94	17.87	10.94	10.57
Tangible Book Value	1,108	1,053	1,054	1,047	526.43	505.01
Tangible Book Value Per Share	18.77	17.84	17.85	17.73	10.73	10.30
Land	83.08	83.08	83.08	83.08	83.08	83.08
Buildings	197.04	197.04	197.04	196.97	196.6	194.3
Machinery	110.11	109.96	105.32	101.48	93.09	77.69
Leasehold Improvements	14.39	14.39	14.39	10.33	9.76	3.41